APA (7th ed.) Citation

Herzog, M., Storch, C. H., Gut, P., Kotlyar, D., Füllekrug, J., Ehehalt, R., . . . Weiß, J. (2011). Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity. Naunyn-Schmiedeberg's archives of pharmacology, 383(1), . https://doi.org/10.1007/s00210-010-0568-8

Chicago Style (17th ed.) Citation

Herzog, Melanie, Caroline Henrike Storch, Philipp Gut, Dimitry Kotlyar, Joachim Füllekrug, Robert Ehehalt, Walter E. Haefeli, and Johanna Weiß. "Knockdown of Caveolin-1 Decreases Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) and Increases Chemotherapeutic Sensitivity." Naunyn-Schmiedeberg's Archives of Pharmacology 383, no. 1 (2011). https://doi.org/10.1007/s00210-010-0568-8.

MLA (9th ed.) Citation

Herzog, Melanie, et al. "Knockdown of Caveolin-1 Decreases Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) and Increases Chemotherapeutic Sensitivity." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 383, no. 1, 2011, https://doi.org/10.1007/s00210-010-0568-8.